sq-11725 has been researched along with Pregnancy in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Aziz, PF; Cantillon, D; El Assaad, I; Hammond, BH; Herber, JM; Saarel, EV | 1 |
| Amoussou, M; Kambiré, Y; Konaté, L; Millogo, GR; Nebié, LV; Niakara, A; Sib, E | 1 |
| Goldaniga, G; Montesanti, L; Pianezzola, E; Valzelli, G | 1 |
| Borer, JS; Moses, JW | 1 |
| Keim, GR; Keysser, CH; Kulesza, JS; Miller, MM; Myhre, JL; Sibley, PL; Stevens, AC; Yoon, YH | 1 |
| Moore, F; Seely, EW; Solomon, CG; Thiet, M | 1 |
| Lee, RM; Tsoporis, J; Wang, RR | 1 |
| Fox, RE; Marx, C; Stark, AR | 1 |
1 review(s) available for sq-11725 and Pregnancy
| Article | Year |
|---|---|
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Cardiomyopathy, Hypertrophic; Coronary Disease; Female; Heart Diseases; Heart Failure; Humans; Hypertension; Metoprolol; Mitral Valve Prolapse; Mitral Valve Stenosis; Nadolol; Nervous System Diseases; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Structure-Activity Relationship; Timolol | 1981 |
7 other study(ies) available for sq-11725 and Pregnancy
| Article | Year |
|---|---|
Contemporary maternal and fetal outcomes in the treatment of LQTS during pregnancy: Is nadolol bad for the fetus?
Topics: Adrenergic beta-Antagonists; Adult; Bradycardia; Female; Fetal Diseases; Fetus; Humans; Hypoglycemia; Infant, Newborn; Long QT Syndrome; Nadolol; Pregnancy; Treatment Outcome; Young Adult | 2022 |
Right ventricular outflow tract tachycardia worsened during pregnancy.
Topics: Adult; Anti-Arrhythmia Agents; Catheter Ablation; Drug Therapy, Combination; Female; Flecainide; Hospitalization; Humans; Nadolol; Pregnancy; Pregnancy Complications, Cardiovascular; Tachycardia, Ventricular | 2015 |
Pharmacokinetics and metabolism of a new beta-adrenergic blocking agent, the 1, ter-butyl-amino-3-(1,2,3,4-tetrahydro-1,4-ethano-8-hydroxy-5-naphthoxy)-2-propanol (K 5407).
Topics: Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Animals; Biotransformation; Dogs; Feces; Female; Humans; Injections, Intravenous; Kinetics; Male; Middle Aged; Nadolol; Pregnancy; Propanolamines; Species Specificity; Time Factors | 1980 |
Preclinical safety evaluation of the nadolol/bendroflumethiazide combination in mice, rats, and dogs.
Topics: Animals; Bendroflumethiazide; Blood Glucose; Blood Pressure; Dogs; Drug Combinations; Drug Evaluation, Preclinical; Electrolytes; Female; Heart Rate; Lethal Dose 50; Male; Mice; Nadolol; Pregnancy; Propanolamines; Rats; Species Specificity; Teratogens; Water-Electrolyte Balance | 1984 |
Primary hyperaldosteronism in pregnancy. A case report.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Hyperaldosteronism; Nadolol; Nifedipine; Potassium; Pregnancy; Pregnancy Complications; Renin; Tomography, X-Ray Computed; Vasodilator Agents | 1996 |
Influence of chronic nadolol treatment on blood pressure and vascular changes in spontaneously hypertensive rats.
Topics: Adrenal Glands; Animals; Blood Pressure; Body Weight; Female; Hypertension; Male; Mesenteric Arteries; Nadolol; Norepinephrine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Time Factors | 1992 |
Neonatal effects of maternal nadolol therapy.
Topics: Female; Fetal Distress; Growth Disorders; Humans; Hypertension; Hypoglycemia; Infant, Newborn; Male; Nadolol; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects; Propanolamines | 1985 |